Efficacy of Immune Checkpoint Inhibitors in Metastatic Melanoma (MM) Patients with Concurrent Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Guerra, Veronica [1 ]
Ologun, Gabriel [2 ]
Haydu, Lauren [2 ]
Keung, Emily [2 ]
Burton, Elizabeth [2 ]
Tawbi, Hussein [3 ]
Davis, Michael [3 ]
Wargo, Jennifer [2 ]
Ferrajoli, Alessandra [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
chronic lymphocytic leukemia; CLL; melanoma; immune checkpoint inhibitors; nivolumab; ipilimumab; pembrolizumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-229
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [1] Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia
    Cass, S. H.
    Tobin, J. W. D.
    Seo, Y. D.
    Gener-Ricos, G.
    Keung, E. Z.
    Burton, E. M.
    Davies, M. A.
    Mcquade, J. L.
    Lazar, A. J.
    Mason, R.
    Millward, M.
    Sandhu, S.
    Khoo, C.
    Warburton, L.
    Guerra, V.
    Haydon, A.
    Dearden, H.
    Menzies, A. M.
    Carlino, M. S.
    Smith, J. L.
    Mollee, P.
    Burgess, M.
    Mapp, S.
    Keane, C.
    Atkinson, V.
    Parikh, S. A.
    Markovic, S. N.
    Ding, W.
    Call, T. G.
    Hampel, P. J.
    Long, G., V
    Wargo, J. A.
    Ferrajoli, A.
    ANNALS OF ONCOLOGY, 2023, 34 (09) : 796 - 805
  • [2] Checkpoint Blockade in Melanoma Patients With Underlying Chronic Lymphocytic Leukemia
    Smithy, James W.
    Pianko, Matthew J.
    Maher, Colleen
    Postow, Michael A.
    Shoushtari, Alexander N.
    Momtaz, Parisa
    Chapman, Paul B.
    Wolchok, Jedd D.
    Park, Jae H.
    Callahan, Margaret K.
    JOURNAL OF IMMUNOTHERAPY, 2021, 44 (01) : 9 - 15
  • [3] The impact of immune checkpoint inhibitors in patients with chronic lymphocytic leukemia (CLL) A protocol for a systematic review and meta-analysis of randomized controlled trials
    Ntsethe, Aviwe
    Dludla, Phiwayinkosi Vusi
    Nyambuya, Tawanda Maurice
    Ngcobo, Siphamandla Raphael
    Nkambule, Bongani Brian
    MEDICINE, 2020, 99 (28) : E21167
  • [4] Sargramostim and immune checkpoint inhibitors: combinatorial therapeutic studies in metastatic melanoma
    Tarhini, Ahmad A.
    Joshi, Ila
    Garner, Fiona
    IMMUNOTHERAPY, 2021, 13 (12) : 1011 - 1029
  • [5] Immune checkpoint inhibitors retain effectiveness in older patients with cutaneous metastatic melanoma
    Howell, Ashley, V
    Gebregziabher, Mulugeta
    Thiers, Bruce H.
    Paulos, Chrystal M.
    Wrangle, John M.
    Hunt, Kelly J.
    Wallace, Kristin
    JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (03) : 394 - 401
  • [6] Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors
    Winter, Johanna
    Lenders, Max M.
    Gassenmaier, Maximilian
    Forschner, Andrea
    Leiter, Ulrike
    Weide, Benjamin
    Purde, Mette-Triin
    Flatz, Lukas
    Cozzio, Antonio
    Rocken, Martin
    Garbe, Claus
    Eigentler, Thomas K.
    Wagner, Nikolaus B.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (04) : 1089 - 1099
  • [7] Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors
    Costa Svedman, Fernanda
    Jalsenius, Marie
    Hoeiom, Veronica
    Grozman, Vitali
    Bergqvist, Mattias
    Soederdahl, Fabian
    Eriksson, Hanna
    Rotstein, Samuel
    Ny, Lars
    Ascierto, Paolo A.
    Brage, Suzanne Egyhazi
    Helgadottir, Hildur
    CANCERS, 2022, 14 (03)
  • [8] Impact of clinicopathological characteristics on survival in patients treated with immune checkpoint inhibitors for metastatic melanoma
    Zhao, Bin
    Zhao, Hong
    Zhao, Jiaxin
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (01) : 169 - 177
  • [9] Sudden Otovestibular Dysfunction in 3 Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibitors
    Stuermer, Suzan H.
    Lechner, Axel
    Berking, Carola
    JOURNAL OF IMMUNOTHERAPY, 2021, 44 (05) : 193 - 197
  • [10] Auto-immune hemolytic anemia and hemophagocytic lymphohistiocytosis as immune-related adverse event in patients with metastatic melanoma and concurrent chronic lymphocytic leukemia: a case series and literature review
    Dirven, Iris
    Vander Mijnsbrugge, An-Sofie
    Mignon, Sacha
    Tijtgat, Jens
    Kint, Nicolas
    Neyns, Bart
    MELANOMA RESEARCH, 2023, 33 (04) : 338 - 344
12345